Quality of life in oncology and quality of life in course of molecularly targeted therapy in patients diagnosed with metastatic renal-cell carcinoma
Journal Title: OncoReview - Year 2011, Vol 1, Issue 4
Abstract
Introduction of molecularly targeted agents into clinical practice has led to marked progress in pharmacotherapy of advanced renal cell carcinoma. There have been six drugs of the therapeutic class registered to date. Further registration is expected next year. Targeted therapy proved to prolong time to disease progression of renal cell cancer. If administered sequentially they prolong overall survival as well. The treatment usually tends to last. The disease gains status of chronic illness. Molecular predictive factors are not available and decisions regarding specific therapeutic choices are based on clinical factors. Due to all aforementioned the toxicity profile and related quality of life should be of special interest. The article is the discussion of methodology of quality of life clinical trials, the data collection, data analysis and review of current knowledge regarding this issue in context of treatment of renal cell carcinoma based on molecularly targeted therapy.
Authors and Affiliations
Jakub Żołnierek, Piotr Wysocki
Keywords
Related Articles
- EP ID EP53129
- DOI -
- Views 221
- Downloads 0
The role of vena cava inferior filters in the prevention of venous thromboembolism prior to oncological surgeries
Venous thromboembolism represents one of the most important causes of complications and mortality in cancer patients. The therapy in this group of patients is mainly focused on adequate anticoagulant prophylaxis. In diff...
Merkel cell carcinoma
Merkel cell carcinoma (MCC) is a rare cutaneous malignancy, with aggressive behaviour. The discovery of MCC polyomavirus (MCPyV) provided a major insight into pathogenesis of MCC, as MCPyV is present in most MCC tumours....
Cardiovascular complications of selected antibodies used in oncological immunotherapy
Immunotherapy supports other therapeutic methods and is an important element in the fight against cancer. Its main tasks include stimulation and guidance of the immune system to fight cancer, inhibition of the mechanisms...
Fertility and breast cancer
Breast cancer is the most common cancer among females worldwide. The mean age of breast cancer patients is > 60 yrs old, and it is seldom found in women < 40 yrs old (6.5%) and in very young women < 35 yrs old (0.6%). In...
Rola kinaz JAK w patogenezie nowotworów mieloproliferacyjnych Philadelphia-ujemnych. Możliwości terapii celowanej
W ostatnich latach dokonał się istotny postęp w zrozumieniu patogenezy nowotworów mieloproliferacyjnych, w szczególności tych z mutacjami w obrębie genu JAK2. W 2005 roku liczne grupy badawcze potwierdziły występowanie m...